SATELLITE DIAGNOSTIC AND TREATMENT CLINIC CORE SUMMARY The Satellite Diagnostic and Treatment Clinic Core ( Satellite Core ) is a longstanding component of the ADRC. It operates together with and in the same vein as the Clinical Core, but serves the primary purpose of enriching for individuals from under-represented minority groups. Thus the Core distinguishes itself in that: (a) its primary purpose is enrollment of minorities; (b) participants also receive clinical care in addition to research evaluations; (c) it is an important part of the community enabling highly expert clinical care of persons with cognitive concerns or dementia who are part of minority groups, and may not have resources to seek such care elsewhere; (d) it serves the Spanish-speaking community. Since 2011, the Core has been at the New York State Psychiatric Institute.
The aims of the Satellite Core are like those of the Clinical Core, but with emphasis on minority recruitment and care. Like the Clinical Core, there is an emphasis on recruitment of persons with milder symptoms, such as persons with mild cognitive impairment, in addition to persons with dementia. The Core also continues to recruit participants with less usual or mixed dementias, to promote better neuropathological and molecular understanding of atypical disorders, including Frontotemporal Dementia, Dementia with Lewy Bodies, and Vascular Cognitive Impairment. Risk factors differ in the minority population, and thus vascular, depressive, and other medical disease components may have greater impact in Satellite enrollees. Participants and data obtained in the Satellite Core join that of the Clinical Core as a shared resource for the entire ADRC. The Core interacts with Outreach, Recruitment, & Education Core (recruitment and training), Data Management and Statistical Core (data storage, retrieval, and management), Neuropathology Core (arranging brain autopsy, and providing related clinical data), and Genetics Core (providing DNA samples for genetic analyses, and clinical data). Primary core activities are to recruit participants, perform detailed evaluations, and provide data and resources for use by other Cores, Projects, and Pilot Projects, as well as national and international collaborations, including the National Alzheimer s Coordinating Center (NACC). Evaluations include detailed medical interviews and examinations, neurological examinations, NACC-UDS and Columbia-specific neuropsychological testing, blood samples for plasma and DNA preparation and storage by the Genetics Core, increasing CSF and neuroimaging data, and ultimately brain neuropathological specimens for participants consenting to brain autopsy. Participants are informed of other trials and projects, and encouraged to participate in these important imaging, instrument, drug study, and other trials. The Satellite Core provides training to students, residents, fellows, and investigators. Participant data, images, and biological specimens, including plasma, DNA, CSF, brain tissue are shared with ADRC, other Columbia, and extramural investigators to improve diagnosis, understanding and treatment of aging and dementia, promoting basic and translational research at Columbia, in the New York area, and nationwide.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Specialized Center (P50)
Project #
5P50AG008702-30
Application #
9756277
Study Section
Special Emphasis Panel (ZAG1)
Project Start
Project End
2021-05-31
Budget Start
2019-06-01
Budget End
2020-05-31
Support Year
30
Fiscal Year
2019
Total Cost
Indirect Cost
Name
Columbia University (N.Y.)
Department
Type
DUNS #
621889815
City
New York
State
NY
Country
United States
Zip Code
10032
Gallagher, Damien; Kiss, Alex; Lanctot, Krista L et al. (2018) Toward Prevention of Mild Cognitive Impairment in Older Adults With Depression: An Observational Study of Potentially Modifiable Risk Factors. J Clin Psychiatry 80:
Barnes, Josephine; Bartlett, Jonathan W; Wolk, David A et al. (2018) Disease Course Varies According to Age and Symptom Length in Alzheimer's Disease. J Alzheimers Dis 64:631-642
Burke, Shanna L; Maramaldi, Peter; Cadet, Tamara et al. (2018) Decreasing hazards of Alzheimer's disease with the use of antidepressants: mitigating the risk of depression and apolipoprotein E. Int J Geriatr Psychiatry 33:200-211
Qian, Winnie; Fischer, Corinne E; Schweizer, Tom A et al. (2018) Association Between Psychosis Phenotype and APOE Genotype on the Clinical Profiles of Alzheimer's Disease. Curr Alzheimer Res 15:187-194
Gallagher, Damien; Kiss, Alex; Lanctot, Krista et al. (2018) Depression and Risk of Alzheimer Dementia: A Longitudinal Analysis to Determine Predictors of Increased Risk among Older Adults with Depression. Am J Geriatr Psychiatry 26:819-827
Haaksma, Miriam L; Calderón-Larrañaga, Amaia; Olde Rikkert, Marcel G M et al. (2018) Cognitive and functional progression in Alzheimer disease: A prediction model of latent classes. Int J Geriatr Psychiatry 33:1057-1064
Bravo, Francisca Vaz; Da Silva, Jorge; Chan, Robin Barry et al. (2018) Phospholipase D functional ablation has a protective effect in an Alzheimer's disease Caenorhabditis elegans model. Sci Rep 8:3540
Ramsey, Christine M; Gnjidic, Danijela; Agogo, George O et al. (2018) Longitudinal patterns of potentially inappropriate medication use following incident dementia diagnosis. Alzheimers Dement (N Y) 4:1-10
Grivel, Margaux M; Leong, Wei; Masucci, Michael D et al. (2018) Impact of lifetime traumatic experiences on suicidality and likelihood of conversion in a cohort of individuals at clinical high-risk for psychosis. Schizophr Res 195:549-553
Hadjichrysanthou, Christoforos; McRae-McKee, Kevin; Evans, Stephanie et al. (2018) Potential Factors Associated with Cognitive Improvement of Individuals Diagnosed with Mild Cognitive Impairment or Dementia in Longitudinal Studies. J Alzheimers Dis 66:587-600

Showing the most recent 10 out of 640 publications